TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.

Cancer Med · 2023 · PMC9972139 · PMID 36056685

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

There was a clear trend toward poor OS for T‐ALL patients with a TNFAIP3 mutation although the data were not statistically significant (hazard ratio (HR) = 1.90; 95% confidence interval (CI): 0.89–4.07; 3‐year OS: 20% vs. 43%; p = 0.092).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.